Summary
MetLife, Inc. (MET) has filed an 8-K report on November 21, 2003, to disclose the issuance of $200 million in aggregate principal amount of 5.875% senior notes due November 21, 2033. The notes were sold through an underwriting agreement with Merrill Lynch, Pierce, Fenner & Smith Incorporated, acting as the representative of the underwriters. This issuance is part of MetLife's ongoing debt financing strategy, utilizing an effective shelf registration statement previously filed with the SEC. The transaction represents a strategic move by MetLife to raise capital, likely to support its ongoing business operations, potential acquisitions, or to manage its capital structure. The specific terms of the senior notes, including their interest rate and maturity date, are detailed within the filed agreements and indentures. Investors should note that this filing primarily concerns the debt issuance and does not provide new financial performance data, but rather details on the company's capital raising activities.
Key Highlights
- 1MetLife, Inc. issued $200 million in aggregate principal amount of 5.875% senior notes.
- 2The senior notes have a maturity date of November 21, 2033.
- 3The issuance was facilitated through an underwriting agreement with Merrill Lynch, Pierce, Fenner & Smith Incorporated.
- 4The sale of the senior notes was conducted under a previously filed Form S-3 registration statement.
- 5The filing includes details of the underwriting and pricing agreements.
- 6A fifth supplemental indenture dated November 21, 2003, was executed with J.P. Morgan Trust Company, National Association as trustee.